Regulation of the CaV3.2 calcium channels in health and disease Regulácia CaV3.2 vápnikových kanálov v zdraví a chorobe
Family of T-type or low-voltage activated calcium channels consists of three members: CaV3.1, CaV3.2, and CaV3.3. CaV3.2 channel has almost identical biophysical properties as the CaV3.1 channel, but is distinguished by a specific tissue expression profile and a prominent role in several pathologies...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2017-11-01
|
Series: | European Pharmaceutical Journal |
Subjects: | |
Online Access: | https://doi.org/10.1515/afpuc-2017-0019 |
id |
doaj-5eccd05a93164ff0b76eb1ac00fde26c |
---|---|
record_format |
Article |
spelling |
doaj-5eccd05a93164ff0b76eb1ac00fde26c2021-09-06T19:39:44ZengSciendoEuropean Pharmaceutical Journal2453-67252017-11-01642152110.1515/afpuc-2017-0019Regulation of the CaV3.2 calcium channels in health and disease Regulácia CaV3.2 vápnikových kanálov v zdraví a chorobeLacinová Ľ.0Slovenská akadémia vied, Biomedicínske centrum SAV, Bratislava, SlovakiaFamily of T-type or low-voltage activated calcium channels consists of three members: CaV3.1, CaV3.2, and CaV3.3. CaV3.2 channel has almost identical biophysical properties as the CaV3.1 channel, but is distinguished by a specific tissue expression profile and a prominent role in several pathologies, including neuropathic pain, epilepsy, and dysregulation of cardiac rhythm. Further, it may be involved in phenotype of autism spectrum disorders, and amyotrophic lateral sclerosis. It represents a promising target for future pharmacotherapies.https://doi.org/10.1515/afpuc-2017-0019t-type calcium channel - cav3.2 - regulation - trafficking - glycosylation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lacinová Ľ. |
spellingShingle |
Lacinová Ľ. Regulation of the CaV3.2 calcium channels in health and disease Regulácia CaV3.2 vápnikových kanálov v zdraví a chorobe European Pharmaceutical Journal t-type calcium channel - cav3.2 - regulation - trafficking - glycosylation |
author_facet |
Lacinová Ľ. |
author_sort |
Lacinová Ľ. |
title |
Regulation of the CaV3.2 calcium channels in health and disease Regulácia CaV3.2 vápnikových kanálov v zdraví a chorobe |
title_short |
Regulation of the CaV3.2 calcium channels in health and disease Regulácia CaV3.2 vápnikových kanálov v zdraví a chorobe |
title_full |
Regulation of the CaV3.2 calcium channels in health and disease Regulácia CaV3.2 vápnikových kanálov v zdraví a chorobe |
title_fullStr |
Regulation of the CaV3.2 calcium channels in health and disease Regulácia CaV3.2 vápnikových kanálov v zdraví a chorobe |
title_full_unstemmed |
Regulation of the CaV3.2 calcium channels in health and disease Regulácia CaV3.2 vápnikových kanálov v zdraví a chorobe |
title_sort |
regulation of the cav3.2 calcium channels in health and disease regulácia cav3.2 vápnikových kanálov v zdraví a chorobe |
publisher |
Sciendo |
series |
European Pharmaceutical Journal |
issn |
2453-6725 |
publishDate |
2017-11-01 |
description |
Family of T-type or low-voltage activated calcium channels consists of three members: CaV3.1, CaV3.2, and CaV3.3. CaV3.2 channel has almost identical biophysical properties as the CaV3.1 channel, but is distinguished by a specific tissue expression profile and a prominent role in several pathologies, including neuropathic pain, epilepsy, and dysregulation of cardiac rhythm. Further, it may be involved in phenotype of autism spectrum disorders, and amyotrophic lateral sclerosis. It represents a promising target for future pharmacotherapies. |
topic |
t-type calcium channel - cav3.2 - regulation - trafficking - glycosylation |
url |
https://doi.org/10.1515/afpuc-2017-0019 |
work_keys_str_mv |
AT lacinoval regulationofthecav32calciumchannelsinhealthanddiseaseregulaciacav32vapnikovychkanalovvzdraviachorobe |
_version_ |
1717770160104800256 |